Managing Relationships Between CROs and Clinical Trial Sites
Join us in this special episode of Alira Health’s Podcast “Transformation Talks” with a full cast of Alira Health experts.
In today’s episode our host Kenny Carberry, Associate Director of Clinical Development, and our guests Christopher Rao, Vice President, Peggy Healy, Project Manager, and Kristóf Vajda, Associate Project Manager, explore different challenges and perspectives around building, managing, and maintaining relationships between Clinical CROs and trial site research staff.
LISTEN TO THE EPISODE BELOW
We are pleased to announce that we will be sponsoring and attending ACDM 2023. ACDM23 offers a full two-day program of expert speakers, specialist panels, workshops and debates which(...)
2022 Recap: Your Favorite Alira Health Publications
In 2022, the Alira Health team of scientists, strategists, economists, clinicians, and biostatisticians shared actionable insights, industry thought leadership, and leading-edge guidance(...)
How to Optimize Clinical Research with Patient Advisory Boards
Patient engagement is increasingly essential to all stages of product development—particularly clinical research.
Innovations in Wound Healing
We are excited to attend and sponsor a poster presentation at the Innovations in Wound Healing event this year. This unique meeting is led by a group of experienced educators, scientists(...)
Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials
The rise of technology in clinical research allows us to capture meaningful aspects of health in clinical study participants.
The Promise and Reality of Decentralized and Hybrid Clinical Trials in Europe Today
To understand the challenges related to hybrid and decentralized trials and ways to overcome them, we spoke with Dr. Hervé Solatges, Product Management, Evidence, and Innovation (DCT(...)
Taking In-Licensed Biologics to Market: Challenges, Complexities, and Ways to Overcome Them
Taking a biologic through drug development to market is highly complex and filled with challenges. To understand these challenges, their implications and how to overcome them, we spoke(...)
Subscribe to our newsletter for the latest news, events, and thought leadership